Publications by authors named "P Langmann"

Claim this Profile
D
Dynamics of serum concentrations of antibodies to infliximab: a new approach for predicting secondary loss of response in inflammatory bowel diseases.
Melina K Grasmeier, Anna F Langmann, Peter Langmann, Matthias Treiber, Markus A Thaler

Therap Adv Gastroenterol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid.
Werner J Heinz, Kathrin Kahle, Annegret Helle-Beyersdorf, Diana Schirmer, Ulrike Lenker, Peter Langmann

Cancer Chemother Pharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography.
Kathrin Kahle, Peter Langmann, Diana Schirmer, Ulrike Lenker, Daniela Keller

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low trough levels of tipranavir in a combination antiretroviral therapy of tipranavir/ritonavir and tenofovir require therapeutic drug monitoring.
P Langmann, R Winzer, D Schirmer, W Heinz, M Leyh

Eur J Med Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of long-term lopinavir plasma-levels in patients with liver disease.
Peter Langmann, C Hubert, W Heinz, A Trein, E Schnaitmann

Eur J Med Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis